Product Information
PHENTERMINE 37.5 MG TABLET is a generic product labeled by TAGI Pharma Inc., priced at $0.0697 per EA under NDC 51224010150. Its NADAC has been published 639 times since Nov 28, 2013.
Strength
37.5 mg/1
Manufacturer
TAGI Pharma Inc.NDC
51224010150
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
2/18/2026
Active Ingredients
PHENTERMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA200272On Market Since
3/8/2011
Pharmacological Classes
Price Statistics
The NADAC for PHENTERMINE 37.5 MG TABLET has been published 639 times since Nov 28, 2013, and over the history we have for it it has declined 34.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0697 per EA |
|---|---|
| All-time high | $0.1304 (Apr 16, 2014) |
| All-time low | $0.0494 (Nov 20, 2024) |
| 52-week high | $0.0777 |
| 52-week low | $0.0670 |
| Median price | $0.0905 |
| Average price | $0.0926 |
| Largest weekly change | +51.9% (Jun 19, 2024) |
| Weeks tracked | 639 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PHENTERMINE 37.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PHENTERMINE 37.5 MG TABLET, manufactured by TAGI Pharma Inc., is $0.0697 per EA (NDC 51224010150), effective Feb 18, 2026.
How has the price of PHENTERMINE 37.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for PHENTERMINE 37.5 MG TABLET has declined 34.1%. It has been tracked across 639 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PHENTERMINE 37.5 MG TABLET?
Since Nov 28, 2013, the NADAC for PHENTERMINE 37.5 MG TABLET has ranged from a low of $0.0494 (Nov 20, 2024) to a high of $0.1304 (Apr 16, 2014), with a median of $0.0905 per EA.
Are there cheaper alternatives to PHENTERMINE 37.5 MG TABLET?
7 NADAC-published products share the same active ingredient, strength, and dosage form as PHENTERMINE 37.5 MG TABLET, but none are currently priced below it.
Who manufactures PHENTERMINE 37.5 MG TABLET?
PHENTERMINE 37.5 MG TABLET (NDC 51224010150) is labeled by TAGI Pharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification